Fabry Disease – Family Screening — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Targeted molecular testing for the familial GLA pathogenic variant
Female heterozygotes can have normal or near-normal alpha-galactosidase A activity because of X-chromosome inactivation. Targeted testing for the known familial GLA variant is the appropriate cascade test; enzyme testing is most reliable for affected males. MRI and renal biopsy may contribute to phenotypic assessment after diagnosis but cannot replace molecular testing.
Reference: NHS Genomic Medicine Service: Fabry disease: https://southeastgenomics.nhs.uk/tool/fabry-disease/